Novel drug development for amyotrophic lateral sclerosis
- 1 November 2000
- journal article
- review article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 180 (1-2) , 21-28
- https://doi.org/10.1016/s0022-510x(00)00419-6
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Pathogenesis of amyotrophic lateral sclerosis: a critical reviewCurrent Opinion in Neurology, 1999
- The Role of Excitotoxicity in Neurodegenerative DiseasePharmacology & Therapeutics, 1999
- Parkinson's disease research moves on brisklyThe Lancet, 1999
- Treatment of Amyotrophic Lateral SclerosisDrugs & Aging, 1999
- Amyotrophic lateral sclerosis: lessons in trial design from recent trialsJournal of the Neurological Sciences, 1997
- The Riluzole Early Access Programme: descriptive analysis of 844 patients in FranceZeitschrift für Neurologie, 1997
- Riluzole, a Novel Neuroprotective Agent, Attenuates Both Neurologic Motor and Cognitive Dysfunction Following Experimental Brain Injury in the RatJournal of Neurotrauma, 1996
- Dose-ranging study of riluzole in amyotrophic lateral sclerosisThe Lancet, 1996
- Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993